Innoviva

$0.00 (0.00%) As of 1:22 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Innoviva and other ETFs, options, and stocks.

About INVA

Innoviva, Inc. is engaged in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI.

CEO
Pavel Raifeld
Employees
5
Headquarters
Burlingame, California
Founded
1996

INVA Key Statistics

Market Cap
1.06B
Price-Earnings Ratio
6.07
Dividend Yield
—
Average Volume
697.56K
High Today
$15.30
Low Today
$14.90
Open Price
$15.03
Volume
488.67K
52 Week High
$16.72
52 Week Low
$9.21

INVA Earnings

$0.00
$0.30
$0.60
$0.90
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Oct 27, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure